Plasma Caffeine Levels and Risk of Alzheimer’s Disease and Parkinson’s Disease: Mendelian Randomization Study

Plasma Caffeine Levels and Risk of Alzheimer’s Disease and Parkinson’s Disease: Mendelian Randomization Study

We leveraged genetic variants associated with caffeine metabolism in the two-sample Mendelian randomization framework to investigate the effect of plasma caffeine levels on the risk of Alzheimer’s disease and Parkinson’s disease. Genetic association estimates for the outcomes were obtained from the...

Full description

Bibliographic Details
Main Authors: Susanna C. Larsson, Benjamin Woolf, Dipender Gill
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Nutrients
Subjects:
Alzheimer’s disease
caffeine
coffee
Mendelian randomization
Parkinson’s disease
Online Access:https://www.mdpi.com/2072-6643/14/9/1697

Internet

https://www.mdpi.com/2072-6643/14/9/1697

Similar Items